174 related articles for article (PubMed ID: 17356265)
1. Soy protein and isoflavones influence adiposity and development of metabolic syndrome in the obese male ZDF rat.
Davis J; Higginbotham A; O'Connor T; Moustaid-Moussa N; Tebbe A; Kim YC; Cho KW; Shay N; Adler S; Peterson R; Banz W
Ann Nutr Metab; 2007; 51(1):42-52. PubMed ID: 17356265
[TBL] [Abstract][Full Text] [Related]
2. Soy protein influences the development of the metabolic syndrome in male obese ZDFxSHHF rats.
Davis J; Iqbal MJ; Steinle J; Oitker J; Higginbotham DA; Peterson RG; Banz WJ
Horm Metab Res; 2005 May; 37(5):316-25. PubMed ID: 15971156
[TBL] [Abstract][Full Text] [Related]
3. Gene expression and adiposity are modified by soy protein in male Zucker diabetic fatty rats.
Banz WJ; Davis J; Peterson R; Iqbal MJ
Obes Res; 2004 Dec; 12(12):1907-13. PubMed ID: 15687389
[TBL] [Abstract][Full Text] [Related]
4. Soy protein influences insulin sensitivity and cardiovascular risk in male lean SHHF rats.
Davis J; Steinle J; Higginbotham DA; Oitker J; Peterson RG; Banz WJ
Horm Metab Res; 2005 May; 37(5):309-15. PubMed ID: 15971155
[TBL] [Abstract][Full Text] [Related]
5. (+)-Z-Bisdehydrodoisynolic acid ameliorates obesity and the metabolic syndrome in female ZDF rats.
Banz WJ; Davis J; Steinle JJ; Adler S; Oitker J; Winters TA; Higginbotham DA; Hou Y; Henry N; Peterson R; Meyers CY
Obes Res; 2005 Nov; 13(11):1915-24. PubMed ID: 16339123
[TBL] [Abstract][Full Text] [Related]
6. A casein diet added isoflavone-enriched soy protein favorably affects biomarkers of steatohepatitis in obese Zucker rats.
Gudbrandsen OA; Wergedahl H; Berge RK
Nutrition; 2009 May; 25(5):574-80. PubMed ID: 19101115
[TBL] [Abstract][Full Text] [Related]
7. [Effect of a modified low protein and low fat diet on histologic changes and metabolism in kidneys in an experimental model of polycystic kidney disease].
Banković-Calić N; Ogbori MR; Nicman E
Srp Arh Celok Lek; 2002; 130(7-8):251-7. PubMed ID: 12585002
[TBL] [Abstract][Full Text] [Related]
8. Modulation of methylglyoxal and glutathione by soybean isoflavones in mild streptozotocin-induced diabetic rats.
Lu MP; Wang R; Song X; Wang X; Wu L; Meng QH
Nutr Metab Cardiovasc Dis; 2008 Nov; 18(9):618-23. PubMed ID: 18060748
[TBL] [Abstract][Full Text] [Related]
9. Effects of soy protein and isoflavone on hepatic fatty acid synthesis and oxidation and mRNA expression of uncoupling proteins and peroxisome proliferator-activated receptor gamma in adipose tissues of rats.
Takahashi Y; Ide T
J Nutr Biochem; 2008 Oct; 19(10):682-93. PubMed ID: 18328687
[TBL] [Abstract][Full Text] [Related]
10. Increased serum and testicular androgen levels in F1 rats with lifetime exposure to soy isoflavones.
McVey MJ; Cooke GM; Curran IH
Reprod Toxicol; 2004 Jul; 18(5):677-85. PubMed ID: 15219630
[TBL] [Abstract][Full Text] [Related]
11. Dietary soy protein benefit in experimental kidney disease is preserved after isoflavone depletion of diet.
Ogborn MR; Nitschmann E; Bankovic-Calic N; Weiler HA; Aukema HM
Exp Biol Med (Maywood); 2010 Nov; 235(11):1315-20. PubMed ID: 20921276
[TBL] [Abstract][Full Text] [Related]
12. Preventive effects of a soy-based diet supplemented with stevioside on the development of the metabolic syndrome and type 2 diabetes in Zucker diabetic fatty rats.
Dyrskog SE; Jeppesen PB; Colombo M; Abudula R; Hermansen K
Metabolism; 2005 Sep; 54(9):1181-8. PubMed ID: 16125530
[TBL] [Abstract][Full Text] [Related]
13. Proinflammatory gene expression and renal lipogenesis are modulated by dietary protein content in obese Zucker fa/fa rats.
Tovar-Palacio C; Tovar AR; Torres N; Cruz C; Hernández-Pando R; Salas-Garrido G; Pedraza-Chaverri J; Correa-Rotter R
Am J Physiol Renal Physiol; 2011 Jan; 300(1):F263-71. PubMed ID: 20962115
[TBL] [Abstract][Full Text] [Related]
14. A combination of CLA-DAG oil modifies the diabetic phenotype in male Zucker diabetic fatty rats.
Iqbal MJ; Higginbotham A; Chickris N; Bollaert M; Rockway S; Banz WJ
Horm Metab Res; 2008 Apr; 40(4):262-8. PubMed ID: 18548385
[TBL] [Abstract][Full Text] [Related]
15. Dietary flaxseed meal reduces proteinuria and ameliorates nephropathy in an animal model of type II diabetes mellitus.
Velasquez MT; Bhathena SJ; Ranich T; Schwartz AM; Kardon DE; Ali AA; Haudenschild CC; Hansen CT
Kidney Int; 2003 Dec; 64(6):2100-7. PubMed ID: 14633132
[TBL] [Abstract][Full Text] [Related]
16. Isoflavone-poor soy protein alters the lipid metabolism of rats by SREBP-mediated down-regulation of hepatic genes.
Shukla A; Brandsch C; Bettzieche A; Hirche F; Stangl GI; Eder K
J Nutr Biochem; 2007 May; 18(5):313-21. PubMed ID: 16962760
[TBL] [Abstract][Full Text] [Related]
17. Dietary soy protein reduces early renal disease progression and alters prostanoid production in obese fa/fa Zucker rats.
Hwang SY; Taylor CG; Zahradka P; Bankovic-Calic N; Ogborn MR; Aukema HM
J Nutr Biochem; 2008 Apr; 19(4):255-62. PubMed ID: 17656081
[TBL] [Abstract][Full Text] [Related]
18. Ginseng modifies the diabetic phenotype and genes associated with diabetes in the male ZDF rat.
Banz WJ; Iqbal MJ; Bollaert M; Chickris N; James B; Higginbotham DA; Peterson R; Murphy L
Phytomedicine; 2007 Oct; 14(10):681-9. PubMed ID: 17689944
[TBL] [Abstract][Full Text] [Related]
19. Soy affects trabecular microarchitecture and favorably alters select bone-specific gene expressions in a male rat model of osteoporosis.
Soung DY; Devareddy L; Khalil DA; Hooshmand S; Patade A; Lucas EA; Arjmandi BH
Calcif Tissue Int; 2006 Jun; 78(6):385-91. PubMed ID: 16830200
[TBL] [Abstract][Full Text] [Related]
20. Effects of soy vs. casein protein on body weight and glycemic control in female monkeys and their offspring.
Wagner JD; Jorgensen MJ; Cline JM; Lees CJ; Franke AA; Zhang L; Ayers MR; Schultz C; Kaplan JR
Am J Primatol; 2009 Sep; 71(9):802-11. PubMed ID: 19484707
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
